(1)
Kjellin , M.; Wesslén , T.; Löfblad , E.; Lennerstrand , J.; Lannergård , A. The Effect of the First-Generation HCV-Protease Inhibitors Boceprevir and Telaprevir and the Relation to Baseline NS3 Resistance Mutations in Genotype 1: Experience from a Small Swedish Cohort. ujms 2018, 123, 50–56.